ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI

Inclusion Criteria: * Adults ≥18 and ≤ 40 years of age at time of Informed Consent * Informed Consent as documented by signature * No known chronic conditions (defined by ICD-10 codes) * Non-smoking * French speaking Exclusion Criteria: * Women who are pregnant or breast feeding, * Intention to become pregnant during the course of the study, * Contraindications to the class of drug (gadopiclenol and gadoteric acid) under study, e.g. known hypersensitivity or allergy * Claustrophobia and contraindication for MRI according to institutional practices * Prior MRI examination with contrast agent and washout period of ≤ 2 weeks * Prior liver, spleen, pancreatic or bowel surgery * Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) * Known or suspected non-compliance, drug or alcohol abuse * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant * Participation in another study with investigational medicinal product within the 30 days preceding and during the present study